If travelling to remote areas without reliable refrigeration, consult your pharmacist about the maximum duration your specific GLP-1 product can remain at room temperature, and plan your medication supply accordingly
Phase 2 showed 24.2% weight loss at 48 weeks
The C-terminal of hormone binds to the extracellular domain, while the N-terminal interacts with the transmembrane domain of the receptor (43)
In a systematic literature review of randomized controlled trials of GLP-1 based therapy in patients with obesity without T2DM, adverse events were reported in 8096 % of patients treated with liraglutide or semaglutide compared with 6396 % of placebo-treated patients
The FDA has explicitly warned consumers about unapproved GLP-1 products
Beyond their effectiveness in glycemic control, these therapies also promote weight loss, making them beneficial for patients with overweight or obesity alongside type 2 diabetes